As of Feb 17
| +0.06 / +3.57%|
The 2 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +187.36% increase from the last price of 1.74.
The current consensus among 3 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.